175 related articles for article (PubMed ID: 23695172)
1. Increased perioperative b-type natriuretic peptide associates with heart failure hospitalization or heart failure death after coronary artery bypass graft surgery.
Fox AA; Nascimben L; Body SC; Collard CD; Mitani AA; Liu KY; Muehlschlegel JD; Shernan SK; Marcantonio ER
Anesthesiology; 2013 Aug; 119(2):284-94. PubMed ID: 23695172
[TBL] [Abstract][Full Text] [Related]
2. Plasma corin decreases after coronary artery bypass graft surgery and is associated with postoperative heart failure: a pilot study.
Barnet CS; Liu X; Body SC; Collard CD; Shernan SK; Muehlschlegel JD; Jarolim P; Fox AA
J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):374-81. PubMed ID: 25649697
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting.
Fox AA; Muehlschlegel JD; Body SC; Shernan SK; Liu KY; Perry TE; Aranki SF; Cook EF; Marcantonio ER; Collard CD
Anesthesiology; 2010 Apr; 112(4):842-51. PubMed ID: 20216395
[TBL] [Abstract][Full Text] [Related]
4. Increased peak postoperative B-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery.
Fox AA; Marcantonio ER; Collard CD; Thoma M; Perry TE; Shernan SK; Muehlschlegel JD; Body SC
Anesthesiology; 2011 Apr; 114(4):807-16. PubMed ID: 21427536
[TBL] [Abstract][Full Text] [Related]
5. Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting.
Fox AA; Shernan SK; Collard CD; Liu KY; Aranki SF; DeSantis SM; Jarolim P; Body SC
J Thorac Cardiovasc Surg; 2008 Aug; 136(2):452-61. PubMed ID: 18692657
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death.
Scirica BM; Cannon CP; Sabatine MS; Jarolim P; Sloane S; Rifai N; Braunwald E; Morrow DA;
Clin Chem; 2009 Feb; 55(2):265-73. PubMed ID: 19074516
[TBL] [Abstract][Full Text] [Related]
7. A-type and B-type natriuretic peptides in cardiac surgical procedures.
Berendes E; Schmidt C; Van Aken H; Hartlage MG; Rothenburger M; Wirtz S; Scheld HH; Brodner G; Walter M
Anesth Analg; 2004 Jan; 98(1):11-19. PubMed ID: 14693575
[TBL] [Abstract][Full Text] [Related]
8. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
9. Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patients.
Schachner T; Wiedemann D; Fetz H; Laufer G; Kocher A; Bonaros N
Clinics (Sao Paulo); 2010; 65(12):1239-45. PubMed ID: 21340210
[TBL] [Abstract][Full Text] [Related]
10. Postoperative increase in B-type natriuretic peptide levels predicts adverse outcome after cardiac surgery.
Nozohoor S; Nilsson J; Algotsson L; Sjögren J
J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):469-75. PubMed ID: 20829070
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy.
El-Saed A; Voigt A; Shalaby A
Clin Cardiol; 2009 Nov; 32(11):E33-8. PubMed ID: 19816874
[TBL] [Abstract][Full Text] [Related]
12. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery.
Holm J; Vidlund M; Vanky F; Friberg Ö; Håkanson E; Walther S; Svedjeholm R
Br J Anaesth; 2014 Jul; 113(1):75-82. PubMed ID: 24727704
[TBL] [Abstract][Full Text] [Related]
13. Responder to BNP-guided treatment in heart failure. The process of defining a responder.
Karlström P; Dahlström U; Boman K; Alehagen U
Scand Cardiovasc J; 2015; 49(6):316-24. PubMed ID: 26153427
[TBL] [Abstract][Full Text] [Related]
14. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials.
Feldman AM; Mann DL; She L; Bristow MR; Maisel AS; McNamara DM; Walsh R; Lee DL; Wos S; Lang I; Wells G; Drazner MH; Schmedtje JF; Pauly DF; Sueta CA; Di Maio M; Kron IL; Velazquez EJ; Lee KL
Circ Heart Fail; 2013 May; 6(3):461-72. PubMed ID: 23584092
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real-world population.
Zile MR; Desai AS; Agarwal R; Bharmi R; Dalal N; Adamson PB; Maisel AS
Clin Cardiol; 2020 Dec; 43(12):1501-1510. PubMed ID: 32949178
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Get With the Guidelines-Heart Failure Risk Score in Patients With Chronic Heart Failure After Hospitalization.
Suzuki S; Yoshihisa A; Sato Y; Kanno Y; Watanabe S; Abe S; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Ishida T; Takeishi Y
J Am Heart Assoc; 2018 Sep; 7(17):e008316. PubMed ID: 30371158
[TBL] [Abstract][Full Text] [Related]
18. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.
Bolliger D; Seeberger MD; Lurati Buse GA; Christen P; Rupinski B; Gürke L; Filipovic M
Anesth Analg; 2009 Apr; 108(4):1069-75. PubMed ID: 19299763
[TBL] [Abstract][Full Text] [Related]
19. Troponin T and B-type natriuretic peptide after on-pump cardiac surgery: prognostic impact on 12-month mortality and major cardiac events after adjustment for postoperative complications.
Lurati Buse GA; Bolliger D; Seeberger E; Kasper J; Grapow M; Koller MT; Seeberger MD; Filipovic M
Circulation; 2014 Sep; 130(12):948-57. PubMed ID: 25098242
[TBL] [Abstract][Full Text] [Related]
20. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
